Xarelto Lawsuit Update
Johnson & Johnson and Bayer Win Third Xarelto Trial
August 22, 2017
A federal jury in Mississippi has ruled in favor of defendants Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson) and Bayer in a bellwether case brought by a woman who claimed that the blood-thinner Xarelto caused severe gastrointestinal bleeding.
At issue was whether the drug companies had adequately warned patients and doctors of the bleeding risks associated with Xarelto.
The companies have now won three of three bellwether cases, with a fourth pending.
After a 2015 hip replacement, plaintiff Dora Mingo developed deep vein thrombosis, and was prescribed Xarelto. Shortly thereafter, she suffered from gastrointestinal bleeding, and filed a suit in which she claimed that the drug’s makers knew of Xarelto’s dangers but failed to inform doctors and patients of them.
However, the jury in the trial – like the juries in two previous Xarelto trials – found that the drugmakers had taken adequate steps to warn patients of potential side effects.
If you’ve suffered serious complications from the use of Xarelto, don’t let the results of these trials dissuade you from filing a lawsuit that can help you get back on your feet. Every court rules differently, and the expert attorneys at TheLawFirm.com know every angle of “bad drug” cases. Contact us today.
TheLawFirm.com’s award winning lawyers have been featured in over 50 radio and television interviews including:
Real lawyers, real results!
no recovery, no fee!